Currently holds a position at Kancera AB
Position | Company | Period |
---|---|---|
Member of the Management, Chief Executive Officer, Director | Kancera AB | None - |
Independent Director | Klaria Pharma Holding AB (publ) | None - |
Chief Executive Officer, Director | SaltX Technology Holding AB | Dec. 18, 2015 - April 7, 2016 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-08 | 2024-03-06 |
|
B Purchase |
54,348
1.84SEK 9,630 |
54,348 | 1.84 | SEK 100,000 | |
2022-11-14 | 2022-11-04 |
|
B Purchase |
8,339
24.00SEK 20,593 |
8,339 | 24.00 | SEK 200,136 | |
2022-11-04 | 2022-11-04 |
|
B Purchase |
100,068
2.00SEK 20,593 |
100,068 | 2.00 | SEK 200,136 | |
2021-05-14 | 2021-05-12 |
|
B Purchase |
13,001
12.70SEK 16,989 |
13,001 | 12.70 | SEK 165,113 | |
2020-10-01 | 2020-09-30 |
|
B Purchase |
98,263
0.47SEK 4,752 |
98,263 | 0.47 | SEK 46,184 | |
2020-03-26 | 2020-03-25 |
|
B Purchase |
196,527
0.39SEK 7,886 |
196,527 | 0.39 | SEK 76,646 | |
2018-05-17 | 2018-05-16 |
|
B Purchase |
125,000
1.20SEK 15,434 |
125,000 | 1.20 | SEK 150,000 | |
2017-06-01 | 2017-05-30 |
|
B Purchase |
14,230
1.80SEK 2,636 |
14,230 | 1.80 | SEK 25,614 | |
2017-06-01 | 2017-05-30 |
|
B Purchase |
55,795
1.80SEK 10,334 |
55,795 | 1.80 | SEK 100,431 | |
2017-05-19 | 2017-05-18 |
|
S Sale |
300,000
0.08SEK 2,431 |
300,000 | 0.08 | SEK 23,625 | |
2017-05-19 | 2017-05-17 |
|
S Sale |
300,000
0.07SEK 2,277 |
300,000 | 0.07 | SEK 22,125 |
// ... existing code ... // ... rest of the file ...